Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Lancet Regional Health. Americas
|
March 19, 2026
Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada
Sara Carazo, Manale Ouakki, Danuta M Skowronski, et al.
Vaccine
|
November 6, 2019
Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada
Nicholas Brousseau, Danuta M Skowronski, David Bellemare, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 5, 2015
Antibody concentrations against the infecting serotype in vaccinated and unvaccinated children with invasive pneumococcal disease in the United Kingdom, 2006-2013
Nicholas Brousseau, Nick Andrews, Pauline Waight, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 29, 2025
Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods
Sara Carazo, Jonathan Phimmasone, Danuta M Skowronski, et al.
International Journal of Environmental Health Research
|
June 27, 2012
Contamination of public whirlpool spas: factors associated with the presence of Legionella spp., Pseudomonas aeruginosa and Escherichia coli
Nicholas Brousseau, Benoît Lévesque, Thibault A Guillemet, et al.
BMJ Open
|
December 23, 2025
Safety of COVID-19 vaccines among pregnant individuals in Quebec, Canada: a population-based retrospective cohort study from the Canadian Immunization Research Network
Marilou Kiely, Ella Diendere, Isaora Dialahy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age
Gaston De Serres, Nicole Boulianne, Fannie Defay, et al.
Infectious Disease Reports
|
October 28, 2025
Profile, Infection, and Vaccination Uptake: A Cohort of Canadian Retail Workers During the SARS-CoV-2 Pandemic
Mathieu Thériault, Kim Santerre, Nicholas Brousseau, et al.
Infectious Disease Reports
|
December 27, 2024
Infection Rate and Risk Factors of SARS-CoV-2 Infection in Retail Workers at the Onset of the COVID-19 Pandemic, Quebec, Canada
Kim Santerre, Mathieu Thériault, Nicholas Brousseau, et al.
Vaccine
|
July 30, 2024
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants
Gebremedhin B Gebretekle, Man Wah Yeung, Raphael Ximenes, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Lancet Regional Health. Americas
|
March 19, 2026
Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada
Sara Carazo, Manale Ouakki, Danuta M Skowronski, et al.
Vaccine
|
November 6, 2019
Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada
Nicholas Brousseau, Danuta M Skowronski, David Bellemare, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 5, 2015
Antibody concentrations against the infecting serotype in vaccinated and unvaccinated children with invasive pneumococcal disease in the United Kingdom, 2006-2013
Nicholas Brousseau, Nick Andrews, Pauline Waight, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 29, 2025
Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods
Sara Carazo, Jonathan Phimmasone, Danuta M Skowronski, et al.
International Journal of Environmental Health Research
|
June 27, 2012
Contamination of public whirlpool spas: factors associated with the presence of Legionella spp., Pseudomonas aeruginosa and Escherichia coli
Nicholas Brousseau, Benoît Lévesque, Thibault A Guillemet, et al.
BMJ Open
|
December 23, 2025
Safety of COVID-19 vaccines among pregnant individuals in Quebec, Canada: a population-based retrospective cohort study from the Canadian Immunization Research Network
Marilou Kiely, Ella Diendere, Isaora Dialahy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age
Gaston De Serres, Nicole Boulianne, Fannie Defay, et al.
Infectious Disease Reports
|
October 28, 2025
Profile, Infection, and Vaccination Uptake: A Cohort of Canadian Retail Workers During the SARS-CoV-2 Pandemic
Mathieu Thériault, Kim Santerre, Nicholas Brousseau, et al.
Infectious Disease Reports
|
December 27, 2024
Infection Rate and Risk Factors of SARS-CoV-2 Infection in Retail Workers at the Onset of the COVID-19 Pandemic, Quebec, Canada
Kim Santerre, Mathieu Thériault, Nicholas Brousseau, et al.
Vaccine
|
July 30, 2024
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants
Gebremedhin B Gebretekle, Man Wah Yeung, Raphael Ximenes, et al.
Page
of 6